A data analytics tool shows organizations how different COVID-19 testing strategies and other mitigation methods can help reduce the spread of the virus. Read more at Health IT Analytics.
Press Releases · December 7, 2020
The COVID-19 Testing Impact Calculator is a free resource that shows how different approaches to testing and other mitigation measures, such as mask use, can curb the spread of the virus in any organization.
NIBIB in the News · December 2, 2020
Britain has become the first country to license a fully tested covid-19 vaccine. The Economist’s health policy editor explains why this a historic milestone. Read more at Economist..
NIBIB in the News · November 25, 2020
A new tool sponsored by the NIH may be helpful in keeping holiday gatherings -- or any other meeting -- as safe and as coronavirus-free as possible. Watch at CNN.
NIBIB in the News · November 14, 2020
As news emerged this week that an experimental vaccine against covid-19 has proved effective in late-stage clinical trials, hopes that the pandemic’s days may be numbered are running high. Read more at Economist.
NIBIB in the News · November 5, 2020
New SARS-CoV-2 rapid tests, which can deliver results in a matter of minutes in the field rather than taking days in clinical diagnostic labs, are starting to become widely available. Read more at Nature biotechnology.
Science Highlights · November 5, 2020
The COVID-19 Test Us program was conceived soon after the RADx launch in April to facilitate clinical studies for testing technologies in the real-word setting.
NIBIB in the News · November 2, 2020
The coronavirus outbreaks at the White House, first among President Trump and his inner circle and now circulating among Vice President Mike Pence’s staff, illustrate some of the limits of Covid-19 diagnostic tests. Read more at Forbes.
Press Releases · October 6, 2020
NIH, working in collaboration with the Biomedical Advanced Research and Development Authority (BARDA), today announced a third round of contract awards for scale-up and manufacturing of new COVID-19 testing technologies.